C21 Investments Past Performance

How has C21 Investments performed over the past 5 years?

Past Performance Score

2/6

Past Performance Score 2/6

  • Quality Earnings

  • Growing Profit Margin

  • Earnings Trend

  • Accelerating Growth

  • Earnings vs Industry

  • High ROE


30.1%

Historical annual earnings growth

Earnings and Revenue History

Quality Earnings: CXXI has high quality earnings.

Growing Profit Margin: CXXI's current net profit margins (12.7%) are lower than last year (26.1%).


Past Earnings Growth Analysis

Earnings Trend: CXXI has become profitable over the past 5 years, growing earnings by 30.1% per year.

Accelerating Growth: CXXI's has had negative earnings growth over the past year, so it can't be compared to its 5-year average.

Earnings vs Industry: CXXI had negative earnings growth (-55%) over the past year, making it difficult to compare to the Pharmaceuticals industry average (14.5%).


Return on Equity

High ROE: CXXI's Return on Equity (9.9%) is considered low.


Return on Assets


Return on Capital Employed


Discover strong past performing companies